The University of Michigan has synthesized proteolysis targeting chimeras (PROTACs) comprising a von Hippel-Lindau disease tumor suppressor (VHL)-binding moiety coupled to a signal transducer and ...
Hosted on MSN2mon
Merck gets Chinese approval for Welireg for VHL tumorsMerck (NYSE:MRK) has received Chinese regulatory approval for its drug Welireg, also known as belzutifan, for the treatment of certain types of Von Hippel-Lindau, or VHL, disease-associated tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results